24/7 Market News- U.S. government plows more into its existing Moderna contract
DENVER, Colo., July 27, 2020- Moderna (NASDAQ:MRNA) was the weekend’s big Corona winner, as the U.S. government adjusted its existing contract, by increasing funding, by up to $472 million, for a “significantly” larger Phase 3 study of the company’s COVID-19 mRNA vaccine candidate (mRNA-1273). This is the latest Operation Warp Speed development that has been … Continue reading 24/7 Market News- U.S. government plows more into its existing Moderna contract Continue Reading